Your browser doesn't support javascript.
loading
The added value of multi-state modelling in a randomized controlled trial: The HOVON 102 study re-analyzed.
Bakunina, Katerina; Putter, Hein; Versluis, Jurjen; Koster, Eva A S; van der Holt, Bronno; Manz, Markus G; Breems, Dimitri A; Gjertsen, Bjorn T; Cloos, Jacqueline; Valk, Peter J M; Passweg, Jakob; Pabst, Thomas; Ossenkoppele, Gert J; Löwenberg, Bob; Cornelissen, Jan J; de Wreede, Liesbeth C.
Afiliação
  • Bakunina K; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Versluis J; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
  • Koster EAS; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • van der Holt B; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Breems DA; Department of Hematology, Hospital Network Antwerp Stuivenberg/Middelheim, Antwerp, Belgium.
  • Gjertsen BT; Department of Internal Medicine, Hematology section, Haukeland University Hospital, Bergen, Norway.
  • Cloos J; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Valk PJM; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Passweg J; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
  • Pabst T; Department of Hematology, University Hospital Basel, Basel, Switzerland.
  • Ossenkoppele GJ; Department of Medical Oncology, University Hospital/Inselspital, Bern, Switzerland.
  • Löwenberg B; Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Cornelissen JJ; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
  • de Wreede LC; Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
Cancer Med ; 11(3): 630-640, 2022 02.
Article em En | MEDLINE | ID: mdl-34953042
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda